Barely Significant

Excerpts

3,685 sentences · 1 filter applied

Conclusions: The addition of CDK4/6i to ET improves iDFS and shows a favorable trend in DRFS in early-stage HR+/HER2− breast cancer, highlighting the need for longer follow-up to clarify their long-term benefit. early-stage HR+/HER2− breast cancer CDK4/6 inhibitors endocrine therapy adjuvant therapy meta-analysis invasive disease-free survival abemaciclib ribociclib palbociclib Thi
Finally, a study using data from the U.S.–Canada Children’s Oncology Group (COG) showed a marginally significant association between residential exposure to parental insecticide use and the use of professional lawn/landscape services and unilateral retinoblastoma (99 cases, OR 2.8; 1.1–6.7 and OR 2.8; 1.0–8.2, respectively) [ 64 ].
Unsurprisingly, in the overall cohort of 255 patients, no statistically significant differences were observed in disease-free survival (DFS) (HR 0.71, 95% CI 0.48–1.05, p = 0.084) or overall survival (OS) (HR 0.69, 95% CI 0.48–1.05, p = 0.096), although a favorable trend was noted in the surgical arm, suggesting the possibility of a type II error.